Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -.--% | -.--% | -.--% |
2015 | GeneLink Inc. Emerged from Bankruptcy | CI |
2015 | Second Amended Reorganization Plan and Disclosure Statement Approved for GeneLink Inc. | CI |
Sales 2011 | 4.68M 6.43M | Sales 2012 | 2.14M 2.93M | Capitalization | 2.56M 3.51M |
---|---|---|---|---|---|
Net income 2011 | -3M -4.12M | Net income 2012 | -3M -4.12M | EV / Sales 2011 | 2.72 x |
Net Debt 2011 | 429K 588K | Net Debt 2012 | 931K 1.28M | EV / Sales 2012 | 1.63 x |
P/E ratio 2011 |
-2.89
x | P/E ratio 2012 |
-0.71
x | Employees | - |
Yield 2011 * |
-
| Yield 2012 |
-
| Free-Float | 98.38% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Ricciardi
FOU | Founder | 77 | 94-09-20 |
Bernard Kasten
CEO | Chief Executive Officer | 77 | 98-12-31 |
Michael Smith
DFI | Director of Finance/CFO | 56 | 12-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bernard Kasten
CEO | Chief Executive Officer | 77 | 98-12-31 |
Robert Ricciardi
FOU | Founder | 77 | 94-09-20 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 265 | |
-17.86% | 8.35B | |
+45.10% | 3.58B | |
-8.06% | 2.47B | |
-38.71% | 2.46B | |
-7.96% | 2.36B | |
-13.72% | 1.78B | |
-19.73% | 1.53B | |
-40.78% | 1.21B | |
+8.32% | 1.12B |
- Stock Market
- Equities
- GNLKQ Stock